Company: ZCARW
Filing Date: 2025-03-04
Form Type: S-1
Source: 0001213900-25-020176
Chunk: 103

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-04
Form: S-1
Chunk 103
---
 gross proceeds raised by the Placement Agent in the Offering (1.5% with respect to “insiders”), (iii) a five-year placement agent warrant which is currently exercisable for up to 371,962 shares at a current exercise price of $0.806 per share, which reflects an adjustment on February 18, 2025, as a result of the Stockholder approval, and is subject to additional adjustments, in the future and (iv) January/February Series A Placement Agent Warrants and January/February Series B Placement Agent Warrants similar to the January/February Series A Warrants and January/February Series B Warrants issued to the January/February Selling Holders to purchase 10% of the number of shares Common Stock issuable to the January/February Selling Holders pursuant to exercise of the January/February Series A Warrants and the January/February Series B Warrants. The Company also agreed to pay a warrant solicitation fee of 5% of the proceeds received from the cash exercise of any December Series A Warrants. The amount of shares of Common Stock exercisable under the Placement Agent Warrants and the applicable exercise prices have been adjusted as provided in this prospectus. All other terms and conditions of the January/February Offering are the same as those applicable to the December Offering. For information on the terms of the Pre-Funded Warrants, the January/February Series A Warrants and the January/February Series B Warrants, and certain registration rights, see “ Description of Securities.” 53 USE OF PROCEEDS All of the shares of Common Stock offered by the Selling Holders pursuant to this prospectus will be sold by the Selling Holders for their respective accounts. We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the Selling Holders, although we will receive the exercise price of any warrants not exercised by the Selling Holders on a cashless exercise basis. Any proceeds we receive from exercise of the warrants will be used for working capital and general corporate purposes. 54 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with the “Business” section and our unaudited condensed consolidated financial statements for the three and nine months ended December 31, 2024 and 2023, our audited financial statements as of the years ended March 31, 2024